Back to company

InVitroLogics ApS: Financial statements 2023

CVR: 34044562

InVitroLogics ApS (CVR 34044562) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -15,211 and a net result of DKK -15,211 compared with DKK -76,236 the year before. Equity amounted to DKK -410,513.

Gross Profit
-15,211 kr.
Profit/Loss
-15,211 kr.
Equity
-410,513 kr.
Total Assets
10,631 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--15 t.-15 t.-411 t.-
2022--64 t.-76 t.-395 t.0
202148 t.48 t.37 t.-319 t.-
2020--41 t.-41 t.-356 t.-
2019--5 t.-5 t.-315 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

InVitroLogics ApS: The 2022 annual report is outJun 30, 2023

InVitroLogics ApS has published its annual report for 2022. Gross profit came to DKK -64,465, and the net result was DKK -76,236.

About InVitroLogics ApS

InVitroLogics ApS is a Danish company of the type Anpartsselskab based in Slagelse, founded in 2011. The company is registered under the industry Detailhandel med andre medicinske og ortopædiske artikler. The management consists of Claus Pedersen Blicher. The company is owned by ADZUKI HOLDING ApS. In 2025, the company reported a gross profit of DKK -2,448 and a net result of DKK -2,448 compared with DKK -1,327 the year before. Equity amounted to DKK -333,763.